4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-124519
Chief Financial Officer acquired 294,473 shares (conversion)
- Chief Financial Officer returned 294,473 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Bodenstedt Matthias · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-19 | Conversion : show line 1 in the form | +294,473 | 922,009 | D |
| 2025-12-19 | Returned to the company : show line 2 in the form | −294,473 | 0 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-19 | Conversion : show line 3 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG | −8,754 | 0 | D |
Loading xslF345X05/ownership.xml…